First you make a point of dilution, then you go on to say, it doesn't bother you one iota. Why bother to make the point then?
It is, what it is, mudguts. The company is moving forward, and having a go, regardless. Hansen is moving forward, Ablation is moving forward.
Who will reap the rewards?
I do take comfort in the fact, during the last cap raise, management dug deep into their own pockets, in the vicinity of $500k from memory.
Add to My Watchlist
What is My Watchlist?